Sessions | Scientific Sessions at Hematology 2025

Hematology and Blood Disorders

Hematology is the branch of medicine that focuses on the study of blood, blood-forming organs, and blood disorders. This field encompasses the diagnosis, treatment, and prevention of a range of conditions that affect the blood and its components, including red and white blood cells, platelets, blood vessels, bone marrow, lymph nodes, and the proteins involved in blood clotting and immune responses. Hematologists, the specialists in this field, deal with conditions like anemia, leukemia, lymphoma, hemophilia, and clotting disorders.

Blood disorders can be broadly categorized into conditions that affect blood cell production, blood cell destruction, or the clotting mechanism. These disorders may be genetic, acquired, or caused by other diseases and can have significant impacts on a person’s overall health. Treatment for blood disorders can include medication, blood transfusions, bone marrow transplants, or gene therapy, depending on the specific condition. Hematology research is essential in advancing treatments for these disorders, improving patient outcomes, and contributing to our understanding of the immune system and related conditions.

Anaemia

SUBMIT ABSTRACT

Types of Blood Disorders

Blood disorders encompass a range of diseases and conditions that affect the blood’s components, including red blood cells, white blood cells, platelets, bone marrow, and plasma. These conditions can be genetic or acquired and may lead to various complications, affecting the body's ability to carry oxygen, fight infection, or stop bleeding.

Anemia
Thalassemia
Hemophilia
Leukemia
Lymphoma
Multiple Myeloma
Myelodysplastic Syndromes (MDS)
Myeloproliferative Disorders
Bleeding Disorders
Von Willebrand Disease
Thrombocytopenia
Coagulation Factor Deficiencies
Clotting Disorders
Deep Vein Thrombosis (DVT) and Pulmonary Embolism (PE)
Inherited Thrombophilias
Anticoagulant Therapy
Hematopoietic Stem Cell Transplantation
Autologous vs. Allogeneic Transplan
Graft-Versus-Host Disease (GVHD)
Conditioning Regimens
Red Blood Cell Disorders
Hereditary Spherocytosis and Elliptocytosis
Glucose-6-Phosphate Dehydrogenase (G6PD) Deficiency
Sideroblastic Anemia
White Blood Cell Disorders
Neutropenia
Lymphoproliferative Disorders
Eosinophilia and Hypereosinophilic Syndrome
Bone Marrow Disorders

SUBMIT ABSTRACT

Hematology Nursing

Hematology nursing is a specialized area of nursing practice that focuses on patients with blood disorders, including anemia, leukemia, lymphoma, hemophilia, sickle cell disease, and other blood-related malignancies. Hematology nurses are trained to provide specialized care, manage complex symptoms, and support patients through their treatment and recovery processes.

Key Topics:

Nursing Care in Leukemia
Psychosocial Support
Pain Management and Symptom Control
Monitoring and Preventing Complications
Monitoring Transfusion Reactions
Educational Interventions
Patient Education and Family Support
Innovations in Pain Management
Psychosocial Impact of Hematologic Disorders

Nursing

SUBMIT ABSTRACT

Neuro-Hematology

Neuro-hematology is an interdisciplinary field combining elements of both neurology and hematology. It focuses on disorders where the central nervous system (CNS) interacts with hematologic conditions. This includes a range of diseases, such as blood disorders affecting the brain and spinal cord, or neurological complications arising from hematologic diseases like leukemia, lymphoma, and hemophilia.
Neuro-hematology explores the pathophysiological mechanisms linking blood-related disorders and neurological manifestations, and focuses on diagnosis, treatment, and prevention of these overlapping conditions.

key Topics:

Hemorrhagic Strokes and Coagulation Disorders
Cerebral Venous Sinus Thrombosis (CVST)
Neurological Manifestations in Leukemia and Lymphoma
Thrombocytopathy and Bleeding in Neurology
Sickle Cell Disease and Neurological Complications
Neurodegenerative Diseases and Hematologic Disorders
Blood-Brain Barrier and Hematologic Disorders
Neuro-Hematology of Thrombosis and Antithrombotic Therapy
Neuropsychological Impact of Blood Disorders
Neuroinflammation and Hematologic Malignancies
Blood-Brain Barrier (BBB) Permeability in Hematologic Disorders
Neurotoxicity of Hematologic Cancer Treatments
Stroke Prevention in Sickle Cell Disease
Neuro-immune Mechanisms in Hematologic Malignancies
Improving Cognitive Rehabilitation in Hematologic Patients
Management of Neurological Complications in Thrombophilia
Psychological and Cognitive Impact of Hematologic Diseases
Neurovascular Events in Hematologic Disorder

SUBMIT ABSTRACT

Bone Marrow and other Transplantation

Bone and other transplantation therapies are critical for treating a range of hematologic, immunologic, and metabolic disorders. This session will explore the latest advancements in bone marrow and other organ or stem cell transplants, covering their therapeutic applications, challenges, and innovations. Key topics will include both established and experimental approaches to transplantation and the research trends shaping future treatment protocols.

key Topics:

Bone Marrow Transplantation (BMT) and Its Advancements
Peripheral Blood Stem Cell Transplant (PBSCT)
Umbilical Cord Blood Transplantation
Cord Blood Transplantation Cord blood transplantation
Immunosuppression and its evolution in transplantation
Stem cell biology and advancements in cell expansion technologies
Gene editing and gene therapy approaches in transplantation
Personalized medicine and donor matching protocols

SUBMIT ABSTRACT

Science of Blood Transfusion

Blood transfusion is a medical procedure where blood or blood components are transferred from one person (donor) to another (recipient). It plays a critical role in treating various medical conditions, such as anemia, trauma, surgery, blood loss, and certain hematologic diseases. The science of blood transfusion involves several complex processes, including blood collection, compatibility testing, storage, and the administration of blood or its components to patients.

Key Topics:

Blood Donation and Collection
Blood Grouping and Compatibility Testing
Blood Component Separation
Blood Storage and Preservation
Transfusion Reaction Monitoring and Management
Infectious Disease Screening
Autologous Blood Transfusion
Emerging Technologies in Blood Transfusion
Ethical Considerations and Blood Transfusion
Innovations in Blood Component Storage
Artificial Blood and Blood Substitutes
Immunohematology and Blood Compatibility
Transfusion-Related Adverse Reactions
Point-of-Care Testing for Blood Transfusion
Ethics of Blood Transfusion

SUBMIT ABSTRACT

Iron Deficiency and Anemias

Red blood cell (RBC) disorders and anemias are a group of conditions that affect the production, function, or quality of red blood cells. These conditions can lead to reduced oxygen delivery to tissues, causing symptoms like fatigue, weakness, and pallor. Anemia specifically refers to a decrease in the number or quality of red blood cells, resulting in decreased oxygen-carrying capacity.

Key Topics:

Iron Deficiency Anemia
Vitamin B12 Deficiency Anemia (Cobalamin Deficiency)
Folate Deficiency Anemia
Aplastic Anemia
Hemolytic Anemia
Sickle Cell Disease
Thalassemia
G6PD Deficiency (Glucose-6-Phosphate Dehydrogenase Deficiency)
Polycythemia Vera
Hereditary Spherocytosis
Hemoglobinopathies

SUBMIT ABSTRACT

Thrombosis and Hemostasis

Blood transfusion is a medical procedure where blood or blood components are transferred from one person (donor) to another (recipient). It plays a critical role in treating various medical conditions, such as anemia, trauma, surgery, blood loss, and certain hematologic diseases. The science of blood transfusion involves several complex processes, including blood collection, compatibility testing, storage, and the administration of blood or its components to patients.

Key Topics:

Mechanisms of Hemostasis
Thrombosis Causes and Risk Factors
Anticoagulants and Antiplatelet Therapy
Thrombophilia and Genetic Disorders Thrombosis in Specific Populations
Diagnostics in Thrombosis and Hemostasis
Hemostatic Disorders Bleeding Disorders
Advances in Thrombosis and Hemostasis
Research Pathophysiology of Thrombosis and Hemostasis
Innovations in Antithrombotic Therapy
Genetic and Environmental Factors in Thrombosis
Thrombosis in Cancer
Personalized Medicine in Thrombosis Management
Advances in Diagnostic Tools
Hemostasis Disorders and Treatment Innovations
Clinical Outcomes in Thrombosis and Hemostasis Management

SUBMIT ABSTRACT

Leukemia and Haematological Malignancies

Hematological malignancies are cancers that affect the blood, bone marrow, lymph nodes, and lymphatic system. These include leukemia, lymphoma, myeloma, and other malignancies. Leukemia, in particular, is a type of cancer that originates in blood-forming tissues such as the bone marrow and results in the production of abnormal white blood cells. The abnormal cells can proliferate uncontrollably, impairing normal blood cell production. Leukemia Leukemia is classified based on how quickly it progresses (acute vs. chronic) and the type of blood cell it affects (lymphoid vs. myeloid). It is a cancer of the blood and bone marrow that can lead to problems such as anemia, infection, and bleeding.
Types of Leukemia
Acute Lymphoblastic Leukemia (ALL)
Acute Myeloid Leukemia (AML)
Chronic Lymphocytic Leukemia (CLL)
Chronic Myeloid Leukemia (CML)

Hematological Malignancies Beyond Leukemia
Lymphoma
Multiple Myeloma
Myelodysplastic Syndromes (MDS)
Myeloproliferative Disorders

SUBMIT ABSTRACT

Advanced Treatment and Research in Hematology

Hematology is the branch of medicine that deals with the study of blood, blood-forming organs, and blood diseases. Advanced treatment and research in hematology focus on developing innovative therapies and understanding the underlying mechanisms of blood disorders such as anemia, leukemia, lymphoma, hemophilia, and thrombosis. It includes cutting-edge techniques, experimental treatments, and novel approaches to managing blood-related conditions and improving patient outcomes.

key Topics:

Innovations in Blood Transfusion Therapy
Stem Cell Therapy in Hematology
Targeted Therapies and Precision Medicine
Hematologic Malignancies and Novel Drug Development
Advances in Hemophilia and Coagulation Disorders
Thrombosis and Hemostasis Advances
Red Blood Cell Disorders New Treatments
Myeloproliferative Disorders and Myelodysplastic Syndromes
Bone Marrow Failure Syndromes
Advances in Hematology Diagnostics
Precision Medicine and Biomarker Discovery
Gene Therapy and Editing in Blood Disorders
Immunotherapy and Cellular Therapy
Stem Cell and Bone Marrow Transplant Innovations
Novel Drug Development for Hematologic Cancers
Advanced Blood Disorder Diagnostics
Clinical Trials for Hematological Disorders
Artificial Intelligence in Hematology

SUBMIT ABSTRACT

Blood Disorders Diagnosis and Treatment

Blood disorders refer to a group of conditions that affect the blood’s ability to function properly. These disorders can involve the blood cells (red blood cells, white blood cells, platelets), blood vessels, or the clotting mechanisms of the body. Blood disorders may be congenital (inherited) or acquired, and can have a wide range of causes, from genetic
mutations to environmental factors. Diagnosis often involves blood tests, clinical evaluation, and imaging, while treatments may include medications, transfusions, or other interventions.
Key Topics:

Complete Blood Count (CBC) and Blood Smear
Bone Marrow Biopsy and Aspiration
Genetic Testing for Blood Disorders
Flow Cytometry and Immunophenotyping
Coagulation Testing
Medications for Anemia
Blood Transfusions and Iron Chelation Therapy
Chemotherapy and Targeted Therapies for Blood Cancers
Stem Cell and Bone Marrow Transplants
Gene Therapy for Hematologic Disorders
Clotting Factor Replacement and Anticoagulants
Management of Hemoglobinopathies and Red Blood Cell Disorders
Coagulation Disorders and Bleeding/Clotting Disorders
Management of Blood Cancers
Advancements in Genetic Testing and Personalized Medicine
Gene Therapy for Hemoglobinopathies and Blood Disorders
Immunotherapy for Blood Cancers
Stem Cell and Bone Marrow Transplant Advances
Targeted Therapy for Coagulation Disorders
Improved Blood Transfusion Techniques and Blood Substitutes
Chronic Blood Disorder Management
Artificial Intelligence in Blood Disorder Diagnosis
Understanding Iron Metabolism in Blood Disorder
Emerging Therapies in Blood Disorder Treatment

SUBMIT ABSTRACT

Radiolabelled Blood Elements and Other Imaging Modalities

Radiolabelled blood elements refer to blood components (such as red blood cells, white blood cells, platelets, or plasma) that have been tagged with a radioactive isotope. This technique allows clinicians to track the movement, localization, and behavior of these components within the body using imaging methods. These labeled elements are primarily used in diagnostic imaging, particularly in detecting and monitoring blood disorders, infections, cancers, and various other conditions that affect blood circulation or cellular behavior.
In addition to radiolabelled blood elements, various other imaging modalities such as ultrasound, CT, MRI, and PET scans are utilized in the evaluation and management of hematologic disorders. These imaging techniques help in understanding the anatomy and functioning of organs involved in blood production and circulation, and can also be crucial in the detection and assessment of hematologic malignancies.
Key Topics:

Radiolabelled Blood Cell Imaging
Positron Emission Tomography (PET) and Cancer Imaging
Single-Photon Emission Computed Tomography (SPECT)
Magnetic Resonance Imaging (MRI) in Hematology
Computed Tomography (CT) and Hematology
Ultrasound Imaging in Hematology
Endoscopic Imaging in Hematology
Innovative Radiolabeling Techniques
Molecular Imaging for Hematologic Cancers
Imaging in Bone Marrow Disorders
Artificial Intelligence (AI) in Imaging
Combination Imaging Approaches
Non-invasive Monitoring in Hematologic Diseases
Imaging of Immune System Activity in Hematologic Disorders
Personalized Imaging Approaches in Hematology
Theranostic Approaches in Hematology

SUBMIT ABSTRACT

Clinical Hematology

Clinical Hematology is the branch of medicine that focuses on the diagnosis, treatment, and management of blood disorders. It includes the study of hematologic diseases, the function of blood cells, and the blood-forming organs. Clinical hematologists treat conditions that affect the blood, such as anemia, clotting disorders, leukemias, lymphomas, and various other hematological malignancies. Hematology also involves performing diagnostic tests to analyze blood cells, bone marrow, and other components of the circulatory system.
Key Topics

Anemia and Iron Deficiency
Leukemias and Hematologic Malignancies
Thrombocytopenia and Platelet Disorders
Coagulation Disorders
Hematopoiesis and Bone Marrow Disorders
Sickle Cell Disease and Hemoglobinopathies
Blood Transfusion and Blood Products
Stem Cell Therapy and Bone Marrow Transplantation
Gene Therapy for Hematologic Disorders
Targeted Therapies in Leukemia and Lymphoma
Advances in Stem Cell Transplantation
Platelet and Coagulation Disorders
Hematopoiesis and Bone Marrow Disorders
Advances in Anemia Treatment
Hematologic Cancer Immunotherapy
Infection Prevention and Management in Hematology
Transfusion Medicine Innovations
Personalized Hematology

SUBMIT ABSTRACT

Novel Anticoagulants and Antiplatelet Agents

Novel anticoagulants and antiplatelet agents are a class of drugs designed to prevent blood clot formation in patients at risk of thrombotic events, such as stroke, heart attack, or deep vein thrombosis (DVT). These drugs work by targeting specific pathways in the coagulation cascade or platelet activation process to reduce clotting. Unlike traditional anticoagulants (like warfarin) and antiplatelet drugs (like aspirin), novel agents tend to offer benefits like more predictable effects, fewer drug interactions, and easier dosing schedules.

Key Topics:

Direct Oral Anticoagulants (DOACs)
Targeted Antiplatelet Therapy
Anticoagulants and Platelet Inhibition in Cardiovascular Disease
Novel Oral Anticoagulants (NOACs) in Special Populations
Reversal Agents for Novel Anticoagulants
Novel Anticoagulants in Cancer
Clinical Trial Design and Outcome Measures in Anticoagulation Therapy
Safety and Efficacy in Real-World Populations
Long-Term Safety Data
Reversal Agents for New Anticoagulants
Combination Therapies
Personalized Medicine and Targeted Therapy
Novel Anticoagulants in Cancer Treatment
The Role of NOACs in Atrial Fibrillation
Impact on Bleeding Risk and Management
Cost-Effectiveness of Novel Anticoagulants
Biosimilars for Novel Anticoagulants

SUBMIT ABSTRACT

Pediatric Considerations in Hematologic Disorders

Hematologic disorders in pediatric patients present unique challenges due to the ongoing growth and development of children. These conditions can impact a child's physical health, emotional well-being, and developmental milestones. Pediatric hematology requires specialized knowledge to ensure accurate diagnosis, effective treatment, and comprehensive care tailored to the needs of children. Below are key considerations for hematologic disorders in children:
Key Topics:

Genetic Blood Disorders in Children
Childhood Leukemia and Lymphoma
Bone Marrow and Stem Cell Transplantation in Children
Iron Deficiency and Nutritional Anemias in Children
Hemostasis and Thrombosis in Pediatrics
Infections and Immune-Related Blood Disorders
Emerging Therapies and Clinical Trials in Pediatric Hematology
Long-Term Care and Quality of Life in Pediatric Hematology

SUBMIT ABSTRACT

Future Trends in Hematology: Artificial Intelligence and Big Data

Artificial Intelligence (AI) and Big Data are transforming the field of hematology by improving diagnostic accuracy, tailoring treatment plans, and fostering research driven by data in blood-related conditions. By analyzing large volumes of data—including genetic information, patient histories, and imaging results—AI uncovers patterns and insights that enhance clinical decision-making. In the realm of hematology, Big Data supports the synthesis and examination of extensive datasets, allowing for predictive analytics, risk evaluation, and more focused therapeutic approaches. Collectively, AI and Big Data are leading to a future in hematologic care that is more effective, precise, and customized to address the individual requirements of each patient.
Key Topics:

AI in Hematologic Diagnostics and Imaging
Big Data Analytics in Hematologic Research
Personalized Medicine in Hematology through AI and Big Data
Predictive Analytics and Risk Assessment for Blood Disorders
AI-Driven Drug Discovery and Development in Hematology
Real-World Data in Hematology: Applications and Challenges
Emerging Research Themes in AI and Big Data for Hematology:
Ethical considerations in AI-driven diagnostics and data privacy
Development of AI tools that integrate across healthcare platforms
Innovations in machine learning for rare blood disorder identification
Challenges of bias and transparency in AI algorithms

SUBMIT ABSTRACT

International Conference on

Hematology and Blood Disorders

October 20-21, 2025
City Seasons Suites, Dubai, UAE

Home > Call For Paper

Call For
Paper

Hematology and Blood Disorders

Hematology and Blood Disorders

Types of Blood Disorders

Types of Blood Disorders

Hematology Nursing

Hematology Nursing

Neuro-Hematology

Neuro-Hematology

Bone Marrow and other Transplantation

Bone Marrow and other Transplantation

Science of Blood Transfusion

Science of Blood Transfusion

Iron Deficiency and Anemias

Iron Deficiency and Anemias

Thrombosis and Hemostasis

Thrombosis and Hemostasis

Leukemia and Haematological Malignancies

Leukemia and Haematological Malignancies

Advanced Treatment and Research in Hematology

Advanced Treatment and Research in Hematology

Blood Disorders Diagnosis and Treatment

Blood Disorders Diagnosis and Treatment

Radiolabelled Blood Elements and Other Imaging Modalities

Radiolabelled Blood Elements and Other Imaging Modalities

Clinical Hematology

Clinical Hematology

Novel Anticoagulants and Antiplatelet Agents

Novel Anticoagulants and Antiplatelet Agents

Pediatric Considerations in Hematologic Disorders

Pediatric Considerations in Hematologic Disorders

Future Trends in Hematology: Artificial Intelligence and Big Data

Future Trends in Hematology: Artificial Intelligence and Big Data

Copyright @ Scisynopsis-2025,All Rights Reserved.

International Conference on

Hematology and Blood Disorders

October 20-21, 2025City Seasons Suites, Dubai, UAE

Home > Call For Paper

Call ForPaper

Hematology and Blood Disorders

Hematology and Blood Disorders

Types of Blood Disorders

Types of Blood Disorders

Hematology Nursing

Hematology Nursing

Neuro-Hematology

Neuro-Hematology

Bone Marrow and other Transplantation

Bone Marrow and other Transplantation

Science of Blood Transfusion

Science of Blood Transfusion

Iron Deficiency and Anemias

Iron Deficiency and Anemias

Thrombosis and Hemostasis

Thrombosis and Hemostasis

Leukemia and Haematological Malignancies

Leukemia and Haematological Malignancies

Advanced Treatment and Research in Hematology

Advanced Treatment and Research in Hematology

Blood Disorders Diagnosis and Treatment

Blood Disorders Diagnosis and Treatment

Radiolabelled Blood Elements and Other Imaging Modalities

Radiolabelled Blood Elements and Other Imaging Modalities

Clinical Hematology

Clinical Hematology

Novel Anticoagulants and Antiplatelet Agents

Novel Anticoagulants and Antiplatelet Agents

Pediatric Considerations in Hematologic Disorders

Pediatric Considerations in Hematologic Disorders

Future Trends in Hematology: Artificial Intelligence and Big Data

Future Trends in Hematology: Artificial Intelligence and Big Data

Subscribe To Our Newsletter

Copyright @ Scisynopsis-2025,All Rights Reserved.

October 20-21, 2025
City Seasons Suites, Dubai, UAE

Call For
Paper